Skip to main
ATRC

AtriCure (ATRC) Stock Forecast & Price Target

AtriCure (ATRC) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AtriCure is positioned for success in the medical technology industry with a strong product line, focus on innovation, and expanding global presence, making it a promising investment opportunity. Additionally, its strong financials and recent launch of new products suggest the potential for continued revenue and earnings growth in the future. Overall, AtriCure appears to be well-positioned for long-term success and has a positive outlook.

Bears say

AtriCure is a medical innovator with a negative outlook due to its potential competition in the cardiac surgery market and lower expected sales in the back half of the year. Additionally, their quality measure update could result in less revenue than previously expected. These fundamental reasons, along with a revision in their 2026 outlook, lead to a pessimistic view of the company's stock.

AtriCure (ATRC) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AtriCure and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AtriCure (ATRC) Forecast

Analysts have given AtriCure (ATRC) a Strong Buy based on their latest research and market trends.

According to 7 analysts, AtriCure (ATRC) has a Strong Buy consensus rating as of Sep 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AtriCure (ATRC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.